Program Committee

Say “hello” to the ISPOR 2026 Program Committee!  ISPOR is excited to work with an amazing group of talented and passionate members dedicated to curating a robust slate of sessions and building an impactful program. It’s through their collaboration with ISPOR that we can deliver a meaningful experience to our attendees. 

Co-Chairs

  • Dana Goldman, PhD
    Leonard D. Schaeffer Director of the USC Schaeffer Institute for Public Policy & Government Service, University Professor of Public Policy, Pharmacy, and Economics, USC, USCPrice, Los Angeles, CA, USA
  • Indranil Bagchi, PhD
    Global Head, Pricing & Market Access, GSK, Collegeville, PA, USA
  • Dawn Hershman, MD
    Chief of the Division of Hematology/Oncology, Professor of Medicine and Epidemiology, Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
  • Scott Ramsey, MD, PhD
    Director, Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, WA, USA

Members

Tamás Ágh, MD, MSc, PhD
Research Associate Professor, Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs & Syreon Research Institute, Hungary

Suliman Alghnam, PhD
Executive Director of Surveillance, Saudi Public Health Authority, Saudi Arabia

Patricia Aluko, BPharm, MSc
Global Health Outcomes Lead, Reckitt Health, United Kingdom

Angie Botto-van Bemden, PhD
Patient Partner, Musculoskeletal Research International, USA

 

Anita Brogan, MSc, PhD
Vice President, Value Evidence, Modeling & Communication, AESARA, USA

Richard Chapman, PhD
Chief Science Officer, Center for Innovation & Value Research, USA

Randa Eldessouki, MBBCh, MS, MD
Professor of Public Health and Community Medicine, Faculty of Medicine, Fayoum University, Egypt

Boris Gorsh, PharmD
Senior Director, Global Oncology HEOR, Value & Evidence Generation, Daiichi-Sankyo Inc., USA

Diego Guarin, MD, MPH, MSc
Chair, ISPOR Latin America Consortium Executive Committee, USA

Jason R. Guertin, PhD
Associate Professor, Faculty of Medicine, Université Laval, Canada

Sebastian Heidenreich, BSc, MSc, PhD
Executive Director, Patient-Centered Research, Evidera, United Kingdom

William L. Herring, PhD
Executive Director, Health Economics, RTI Health Solutions, USA

Stacie Hudgens, MSc
Founder and Chief Strategy and Scientific Officer (CSSO), Clinical Outcomes Solutions LLC, USA

Manthan D. Janodia, MPH, PhD
Registrar, Malla Reddy Vishwavidyapeeth (Deemed to be University), India

Min-Hua Jen, PhD
Executive Director, Eli Lilly, United Kingdom

Sheldon Kong, PhD
Contract Research Staff, Quantitative Health Sciences, Cleveland Clinic, USA

David D. Kim, PhD
Assistant Professor, Department of Medicine and Public Health Sciences, University of Chicago, USA

Yifei Liu, BS, MS, PhD
Associate Professor, Division of Pharmacy Practice and Administration, The University of Missouri-Kansas City School of Pharmacy, USA

Siu Hing Lo, MA, MSc, PhD
Director, Acaster Lloyd, United Kingdom

Graciela Luraschi, MS
Professor, J. F. Kennedy University, Argentina

Olena Mandrik, MSc, PharmD, PhD
Senior Research Fellow, The University of Sheffield, United Kingdom

Marjorie Morrison, MHA
Director, Policy & Advocacy, Lymphoma Coalition, Canada

Soumana Nasser, PharmD
Associate Professor, Pharmacy Practice Department, Lebanese American University, Lebanon

Bertalan Nemeth, PhD
Principal Health Economist, Syreon Research Institute, Hungary

Jessica Roydhouse, PhD
Senior Research Fellow, Menzies Institute for Medical Research, University of Tasmania, Australia

Sorochi Van Sickle, PhD
Senior Associate, EMPIRIC Institute, Patient Square Capital, USA

Kimberly Westrich, MA
Chief Strategy Officer, National Pharmaceutical Council, USA

Jennifer Whiteley, MSc, MA, PhD
Vice President, Commercial and Market Access, Research Services, Oracle Health & Life Sciences, USA

Jasmanda H. Wu, MPH, MSc, PhD, FISPE
Senior Director, Insmed Inc., USA